Risk Stratification Using Midregional Proadrenomedullin in the ED

NCT05108883 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
463
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Brahms AG